ABCA1 and atherosclerosis: The assumptions about the participation of the transporter in the systemic mechanisms can be supported by observations in which a decrease in the level of mRNA ABCA1 in circulating white blood cells is determined in patients with atherosclerosis as compared to a control group [89].